Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Conversion
Calculated transaction value
$0

Foresite Capital Management V, Llc 10% owner

Transaction date Aug 10, 2026
Public filing date Aug 10, 2026
Filing lag Filed same day

LTGO daily price context

No linked price history

This asset is not matched to a market-data symbol.

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
445,320 shares @ $0
SEC ownership
Indirect
Transaction code
C
Form
4
Filing identifier
0001104659-26-093580
Filing cohort

Transactions in this filing

Showing 15 of 15
Trades
15
Issuers
1
Estimated value
$2.52M
Buys / sales
1 / 0
Transactions reported in the same official filing
Issuer Transaction Traded Value
Latigo Biotherapeutics, Inc. LTGO Conversion Aug 10, 2026 Not reported
Latigo Biotherapeutics, Inc. LTGO Conversion Aug 10, 2026 $0
Latigo Biotherapeutics, Inc. LTGO Conversion Aug 10, 2026 $0
Latigo Biotherapeutics, Inc. LTGO Conversion Aug 10, 2026 $0
Latigo Biotherapeutics, Inc. LTGO Conversion Aug 10, 2026 $0
Latigo Biotherapeutics, Inc. LTGO Conversion Aug 10, 2026 $0
Latigo Biotherapeutics, Inc. LTGO Conversion Aug 10, 2026 $0
Latigo Biotherapeutics, Inc. LTGO Conversion Aug 10, 2026 $0
Latigo Biotherapeutics, Inc. LTGO Current Conversion Aug 10, 2026 $0
Latigo Biotherapeutics, Inc. LTGO Conversion Aug 10, 2026 $0
Latigo Biotherapeutics, Inc. LTGO Buy Aug 10, 2026 $2.52M
Latigo Biotherapeutics, Inc. LTGO Conversion Aug 10, 2026 $0
Latigo Biotherapeutics, Inc. LTGO Conversion Aug 10, 2026 $0
Latigo Biotherapeutics, Inc. LTGO Conversion Aug 10, 2026 Not reported
Latigo Biotherapeutics, Inc. LTGO Conversion Aug 10, 2026 $0